Recurrent Gene Mutations And Clinical Outcome In The Context Of Lenalidomide Treatment Of Relapsed/Refractory Cll - Results From Multicenter Phase Ii Trial Cll-009

BLOOD(2017)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要